Saifuyuzu
4892.TPharmaceutical
Filed as Cyfuse Biomedical K.K. (2023-03–2026-08)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Shizuka Akieda | 7.31% |
| Masahiro Sanjo | 6.74% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| SBI Ventures Two Co., Ltd. | 4.64% |
| SBI Shinsei Bank, Limited | 2.24% |
| SBI SECURITIES Co., Ltd. | 0.83% |
Ownership history · 74
| Holder | Ratio | Change |
|---|---|---|
| SBI SECURITIES Co., Ltd.2026-05-12 · amended | 0.83% | -2.38pp |
| SBI Shinsei Bank, Limited2026-05-12 · amended | 2.24% | no change |
| SBI Ventures Two Co., Ltd.2026-05-12 · amended | 4.64% | no change |
| Shizuka Akieda2026-04-28 | 7.31% | -1.02pp |
| SBI Shinsei Bank, Limited2026-04-27 · amended | 2.24% | no change |
| SBI SECURITIES Co., Ltd.2026-04-27 · amended | 3.21% | -0.72pp |
| SBI Ventures Two Co., Ltd.2026-04-27 · amended | 4.64% | no change |
| SBI Shinsei Bank, Limited2026-01-23 · amended | 2.24% | -0.10pp |
| SBI SECURITIES Co., Ltd.2026-01-23 · amended | 3.93% | -0.78pp |
| SBI Ventures Two Co., Ltd.2026-01-23 · amended | 4.64% | -0.21pp |
| SBI Shinsei Bank, Limited2025-10-01 · amended | 2.34% | -0.01pp |
| SBI SECURITIES Co., Ltd.2025-10-01 · amended | 4.71% | -0.62pp |
| SBI Ventures Two Co., Ltd.2025-10-01 · amended | 4.85% | -0.03pp |
| SBI Shinsei Bank, Limited2025-09-26 · amended | 2.35% | -0.03pp |
| SBI Ventures Two Co., Ltd.2025-09-26 · amended | 4.88% | -0.05pp |
| SBI SECURITIES Co., Ltd.2025-09-26 · amended | 5.33% | -0.98pp |
| SBI Shinsei Bank, Limited2025-09-12 · amended | 2.38% | -0.02pp |
| SBI Ventures Two Co., Ltd.2025-09-12 · amended | 4.93% | -0.05pp |
| SBI SECURITIES Co., Ltd.2025-09-12 · amended | 6.31% | -1.00pp |
| SBI Shinsei Bank, Limited2025-09-02 · amended | 2.40% | -0.03pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.